Elizabeth Parrish Mba

Elizabeth (Liz) Parrish MBA, is the Founder and CEO of BioViva Sciences

USA Inc. BioViva is committed to extending healthy lifespans using gene

therapy. BioViva works on combinatorial gene therapies with its proprietary

CMV gene therapy delivery platform. Liz is a humanitarian, entrepreneur,

author, and innovator. She is a proponent of the Best Choice Medicine plan

(BCM), a more efficient and streamlined regulatory model around the use of

genetic therapies. She is actively involved in international educational media

outreach and is a founding member of several 501(c)(3) nonprofits in the

space. She considers aging a disease and believes the advancements in

space will lead to healthier and longer lifespans with the added benefit of

safer space travel and curative medicine for patients under 20.

 

She also wrote the foreward to the book: 

Expressive Origins: Tales of How Two Strands of DNA Impact Health and Longevity